pharma · HIV Infections · HIV-1 infection
ViiV Healthcare Pty
ViiV Healthcare Pty Ltd
ViiV Healthcare Pty clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- London, GB
- Founded
- 2009
- Employees
- 1,906
- Programs
- 10
- Drugs
- 27
- Patents
- 0
ViiV Healthcare Pty projects
10 ClinicalTrials.gov programs sponsored by ViiV Healthcare Pty.
ViiV Healthcare Pty has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
219700
ViiV Healthcare Pty Ltd
HIV-1 infection
1 trial -
219816
ViiV Healthcare Pty Ltd
Human immunodeficiency virus (HIV)
1 trial -
221611
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
Rukobia 600 mg prolonged-release tablets
ViiV Healthcare Pty Ltd
Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant (MDR) HIV-1
1 trial -
212580
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
218307
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
222638
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
Visual match to product
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
221794
ViiV Healthcare Pty Ltd
HIV Infections
1 trial -
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
ViiV Healthcare Pty Ltd
human immunodeficiency virus (HIV)
1 trial
Frequently asked questions
How many clinical projects does ViiV Healthcare Pty have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.